Former HPIC customers DJS Antibodies has just been acquired by AbbVie for $255 million
Congratulations to DJS Antibodies, a biotechnology company dedicated to creating the next generation of antibody therapeutics, who started life at HPIC using shared lab bench space and have just been acquired by AbbVie for $255 million. HPIC are currently asking bio tech start-ups to apply for the opportunity to secure […]
WIN! Enter today to get your biotech idea off to a flying start
Are you an innovative start-up (less than 12 months old) with a business idea that is beneficial to the environment and/or human health?
Biotech growth fuelled by Heyford Park Innovation Centre
A biotech start-up founded in the middle of the pandemic by three neuroscientists is expanding at Heyford Park Innovation Centre thanks to their world-leading expertise and access to shared laboratory space. Oxford StemTech follows in the footsteps of major biotechs to have benefited from the financial savings and flexibility afforded by the Innovation Centre’s unique
